Presenter: Gordon Smith, Esq. Join the ME SUD Learning Community in conversation with Gordon Smith, Director of Opioid Response. Dr. Lisa Letourneau will be conducting the interview.
Spotlight Interview with Gordon Smith, Esq. Read More »
Presenter: Nicolette Centanni, PharmD, BCPS, BCGP, BCPP Tianeptine, often termed “gas station heroin” is an antidepressant approved in other countries. Over the past few years, it has become a substance of misuse in the US. We will discuss the pharmacology of tianeptine and how it relates to clinical and therapeutic effects. In addition, we will
Tianeptine: Pharmacology, Misuse and Clinical Implications Read More »
Presenter: Chrystal Fullen, Psy.D Substance use can affect cognition during intoxication, withdrawal, and long-term recovery, sometimes resulting in persistent cognitive impairment. This presentation reviews the cognitive effects of commonly used substances, mild vs major neurocognitive disorder, and neurological risks such as hypoxic brain injury, TBI, stroke, and dementia. Participants will also learn practical approaches to
Invisible Disability: Cognitive Impairment In Substance Use Disorder Read More »
Join Sara E. Wakeman, MD as she presents Innovation in Opiod Disorder Treatment. Learning objectives: Understand the epidemiology of the opioid overdose crisis Describe effective treatments for opioid use disorder Detail innovative approaches to starting medications for opioid use disorder
Innovation in Opioid Use Disorder Treatment Read More »
A 2021 study found that positive involvement of affected others in SUD treatment improves the treatment outcomes for an SUD client regardless of their age and the treatment model used. Conversely, affected others are at a higher risk of developing an SUD themselves. Affected others, commonly composed of impacted family members, friends, and community members, regularly report receiving
A 2021 study found that positive involvement of affected others in SUD treatment improves the treatment outcomes for an SUD client regardless of their age and the treatment model used. Conversely, affected others are at a higher risk of developing an SUD themselves. Affected others, commonly composed of impacted family members, friends, and community members, regularly report receiving
A 2021 study found that positive involvement of affected others in SUD treatment improves the treatment outcomes for an SUD client regardless of their age and the treatment model used. Conversely, affected others are at a higher risk of developing an SUD themselves. Affected others, commonly composed of impacted family members, friends, and community members, regularly report receiving
Young Adult ECHO: Supporting Affected Others | Relationship Violence and SUD Read More »
A 2021 study found that positive involvement of affected others in SUD treatment improves the treatment outcomes for an SUD client regardless of their age and the treatment model used. Conversely, affected others are at a higher risk of developing an SUD themselves. Affected others, commonly composed of impacted family members, friends, and community members, regularly report receiving
A 2021 study found that positive involvement of affected others in SUD treatment improves the treatment outcomes for an SUD client regardless of their age and the treatment model used. Conversely, affected others are at a higher risk of developing an SUD themselves. Affected others, commonly composed of impacted family members, friends, and community members, regularly report receiving
A 2021 study found that positive involvement of affected others in SUD treatment improves the treatment outcomes for an SUD client regardless of their age and the treatment model used. Conversely, affected others are at a higher risk of developing an SUD themselves. Affected others, commonly composed of impacted family members, friends, and community members, regularly report receiving
Young Adult ECHO: Supporting Affected Others | Supporting Grieving Adolescents Read More »
